Carcinoma in situ of eye
ICD-10 D09.2 is a billable code used to indicate a diagnosis of carcinoma in situ of eye.
Carcinoma in situ of the eye refers to a localized cancerous condition where abnormal cells are present in the epithelial layer of the eye but have not invaded deeper tissues. This condition can occur in various parts of the eye, including the conjunctiva, cornea, and eyelids. The most common type of carcinoma in situ affecting the eye is squamous cell carcinoma, which may arise due to prolonged exposure to ultraviolet light, certain viral infections, or pre-existing lesions. Diagnosis typically involves a thorough examination by an ophthalmologist, including visual acuity tests, slit-lamp examination, and possibly biopsy to confirm the presence of atypical cells. Surveillance protocols for patients diagnosed with carcinoma in situ of the eye often include regular follow-up visits to monitor for any changes in the lesions, as well as potential treatment options such as cryotherapy, topical chemotherapy, or surgical excision. The risk of progression to invasive cancer varies depending on factors such as the type of carcinoma, the location, and the patient's overall health. Early detection and management are crucial to prevent progression and preserve vision.
Detailed examination notes, pathology reports, and treatment plans must be documented.
Diagnosis of carcinoma in situ during routine eye exams, follow-up after treatment, and management of lesions.
Ophthalmologists should ensure clear documentation of the lesion's characteristics and any changes over time.
Comprehensive treatment plans, including any systemic therapies or surgical interventions.
Referral for treatment of carcinoma in situ, monitoring for progression to invasive cancer.
Oncologists should coordinate with ophthalmologists for accurate staging and treatment documentation.
Used when surgical intervention is required for carcinoma in situ of the eyelid.
Operative notes detailing the excision and pathology results.
Ophthalmologists must document the extent of the lesion and any reconstructive procedures performed.
Carcinoma in situ of the eye is a pre-invasive condition that, if left untreated, may progress to invasive cancer. Early detection and management are essential to prevent complications and preserve vision.
